Author Topic: AWRE - Aware  (Read 985 times)

whistlerbumps

  • Full Member
  • ***
  • Posts: 125
AWRE - Aware
« on: December 10, 2018, 07:47:14 AM »
Has anyone here looked at Aware (AWRE)?  Trading at $3.50 per share with ~$2.25 per share of net cash.  Company makes biometric software for government and commercial applications.  Historically they have mainly served the government which is a perpetual license business (thus very lumpy) but they have just announced their first commercial sale which is expected to be a SaaS business and a much larger potential market.  Investors may be missing this inflection because the company has no analysts, does not do earnings calls/conferences and the stock is not liquid.

Company has been a good steward of capital historically, paying 3 special dividends from 2012-14 and buying back ~8% of the stock since mid 2016 (no mean feat given liquidity constraints).   Seems like solid downside protection with the chance for material upside if the commercial business gains real traction.  Be interested if anyone has any thoughts.

« Last Edit: December 10, 2018, 12:26:30 PM by Parsad »


whistlerbumps

  • Full Member
  • ***
  • Posts: 125
Re: AWRE - Aware
« Reply #1 on: December 18, 2018, 08:13:23 AM »
Good interview with AWRE's VP of Marketing talking about the company's commercial potential and recent UK govt win.

https://findbiometrics.com/interview-aware-david-benini-knomi-fido-uaf-industry-trends-512110/

whistlerbumps

  • Full Member
  • ***
  • Posts: 125
Re: AWRE - Aware
« Reply #2 on: February 13, 2019, 12:25:08 PM »
Q4 results out and were pretty good.  Revenues up 32.6% y/y and the company noted the signing of other commercial licenses.  Commercial gaining traction has the potential to drive substantial upside to current results.  Net cash of $2.39 per share and ongoing government business should continue to provide solid downside support.